Endometrial polyp

1. Hormone therapy is associated with endometrial polyp in humans (aOR 0.15, 95% CI 0.06–0.40; p < 0.001).

   “Current HT use was inversely associated with EP (aOR = 0.15, 95% CI 0.06-0.40; p < 0.001), though regimen data were unavailable.”

   Humanscurrent use at hysteroscopy; regimen unavailablefemales

   Progesterone receptor variants and hormone therapy use in postmenopausal endometrial polyps: a case-control study

   Clinics (Sao Paulo, Brazil)·15 Oct 2026

More on Hormone therapy

1. PGR +331G/A is associated with endometrial polyp in humans (aOR 0.43, 95% CI 0.17–1.09; p = 0.074).

   “Neither +331G/A nor V660L carrier status was significantly associated with EP after adjustment”

   Humansadjusted analysis of +331G/A carrier statusfemales

   Progesterone receptor variants and hormone therapy use in postmenopausal endometrial polyps: a case-control study

   Clinics (Sao Paulo, Brazil)·15 Oct 2026